Pharmacokinetics of amiloride in renal and hepatic disease

European Journal of Clinical Pharmacology

Volumn 33, Issue 5, 1987, Pages 493-498

  Spahn, H ^a,b   Reuter, K ^a   Mutschler, E ^a   Gerok, W ^c   Knauf, H ^c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

amiloride; liver disease; pharmacokinetics; renal failure; urinary excretion

Indexed keywords

AMILORIDE;

CLINICAL ARTICLE; HEPATITIS; HUMAN; KIDNEY FAILURE; NORMAL HUMAN; NORMAL VALUE; ORAL DRUG ADMINISTRATION; PATIENT; PHARMACOKINETICS; VOLUNTEER;

ADULT; AGED; AMILORIDE; BLOOD PROTEINS; CHROMATOGRAPHY, THIN LAYER; FEMALE; HALF-LIFE; HEPATITIS; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; PROTEIN BINDING;

EID: 0023550715     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00544242     Document Type: Article

References (9)

1. Pharmakokinetic von Triamteren bei Probanden und Patienten mit Leber- und Nierenfunktionsstörungen
2. Veränderungen der Pharmakokinetic von Triamteren und Hydrochlorothiazid nach ein- und mehrmaliger Gabe an Patienten mit akuten und chronischen Lebererkrankungen
3. Fluorimetrische Bestimmung von Amilorid in Humanplasma mittels Dünnschichtchromatographie
4. Limitation on the use of amiloride in early renal failure
5. Elimination kinetics and dosage adjustment of drugs in patients with kidney disease
6. Absorption, distribution and elimination of 14C-amiloride in normal human subjects
7. Kinetics and bioavailability of two formulations of amiloride in man
8. The metabolism of amiloride hydrochloride in man